{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:48:24Z","timestamp":1784692104686,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001502, 81903324, 82273634"],"award-info":[{"award-number":["82001502, 81903324, 82273634"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Women who have polycystic ovary syndrome (PCOS) with high body mass index (BMI) typically have an attenuated ovarian response and decreased follicular size, which are linked to unfavourable clinical outcomes following <jats:italic>in vitro<\/jats:italic> fertilization (IVF) therapy. The follicular output rate (FORT), a qualitative indicator of follicular response, seems to be positively linked to the clinical outcomes of IVF. Progestin-primed ovarian stimulation (PPOS) has become an alternative to gonadotropin-releasing hormone (GnRH) analogues to inhibit the premature luteinizing hormone (LH) surge. As letrozole (LE) shows promise in enhancing ovarian response, we compared PPOS with and without LE for PCOS in high BMI women with a focus on the FORT and associated clinical and pregnancy outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For the recruited 1508 women, ten variables including AFC; age; basal sex hormone level; BMI; infertility type; period of infertility and number of previous IVF attempts were chosen in the propensity score matching (PSM) model to match 1374 women who taken the MPA+ hMG protocol with 134 women who received the MPA+ hMG+ LE treatment at a 1:1 ratio. FORT was selected as the primary outcome measure. The number of oocytes retrieved, viable embryos, hMG dosage, duration, oocyte maturity rate, fertilization rate, and implantation rate were established as secondary outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>FORT was substantially elevated in the MPA+hMG+LE group compared with the MPA+hMG group (61% [35%, 86%] vs. 40% [25%, 60%], P &amp;lt;.001). Interestingly, the LE cotreatment group had a considerably lower mature oocyte rate despite having a similar number of mature oocytes and embryos recovered. The average hMG dosages and durations in the study group were similar to those in the control group. The implantation rate in the study group was numerically higher but without statistic significant than that in the control groups (43.15% (107\/248) vs. 38.59% (115\/298), OR 1.008, 95% CI 0.901-1.127; P &amp;gt;.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The effect of LE combined with PPOS on FORT is better than the effect of the standard PPOS treatment in women with PCOS and a high BMI, but there is no substantially beneficial impact on pregnancy outcomes or the cycle features of COS, including consumption of hMG.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1072170","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T06:24:11Z","timestamp":1677824651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment"],"prefix":"10.3389","volume":"14","author":[{"given":"Yali","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertility Sterility"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: A randomized, controlled trial","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","first-page":"22732","DOI":"10.1038\/s41598-021-02227-w","article-title":"Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh485","article-title":"Impact of overweight and underweight on assisted reproduction treatment","volume":"19","author":"Fedorcsak","year":"2004","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.fertnstert.2010.10.026","article-title":"Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"95","author":"Marquard","year":"2011","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des308","article-title":"The association between severe obesity and characteristics of failed fertilized oocytes","volume":"27","author":"Machtinger","year":"2012","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1242\/dev.114850","article-title":"Mitochondrial dysfunction in oocytes of obese mothers: transmission to offspring and reversal by pharmacological endoplasmic reticulum stress inhibitors","volume":"142","author":"Wu","year":"2015","journal-title":"Development"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der479","article-title":"Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the follicular output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome","volume":"27","author":"Gallot","year":"2012","journal-title":"Hum Reprod"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-mullerian hormone levels are negatively related to follicular output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"Genro","year":"2011","journal-title":"Hum Reprod"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1931716","article-title":"The success of ovulation induction with letrozole and gonadotropins in obese and nonobese women: A study from a tertiary center","volume":"2022","author":"Gowri","year":"2022","journal-title":"Int J Reprod Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.676133","article-title":"Letrozole for female infertility","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13664","article-title":"Do female age and body weight modify the effect of individualized FSH dosing in IVF\/ICSI treatment? a secondary analysis of the OPTIMIST trial","volume":"98","author":"Leijdekkers","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s12884-022-05152-6","article-title":"Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation","volume":"22","author":"Hua","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.2527\/1998.76123079x","article-title":"In vitro maturation and fertilization techniques for assessment of semen quality and boar fertility","volume":"76","author":"Xu","year":"1998","journal-title":"J Anim Sci"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo quality","volume":"3","author":"Cummins","year":"1986","journal-title":"J In Vitro Fert Embryo Transf"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.01.024","article-title":"Letrozole-induced frozen embryo transfer cycles are associated with a lower risk of hypertensive disorders of pregnancy among women with polycystic ovary syndrome","volume":"225","author":"Zhang","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study","volume":"25","author":"Kurzawa","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: A systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum Reprod Update"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/REP-19-0342","article-title":"Necessity for LH in selection and continued growth of the bovine dominant follicle","volume":"159","author":"Gomez-Leon","year":"2020","journal-title":"Reproduction"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh682","article-title":"Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? a dose-finding study","volume":"20","author":"Hugues","year":"2005","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: Understanding the role of the brain","volume":"46","author":"Moore","year":"2017","journal-title":"Front Neuroendocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev155","article-title":"Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients","volume":"30","author":"Goldrat","year":"2015","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13567","article-title":"Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study","volume":"47","author":"Jiang","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew355","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.04.045","article-title":"Analysis of spindle characteristics and embryo quality in mice stimulated with letrozole using polscope imaging","volume":"93","author":"Ganesh","year":"2010","journal-title":"Fertil Steril"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.10107","article-title":"Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture","volume":"61","author":"Hu","year":"2002","journal-title":"Mol Reprod Dev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2013.08.003","article-title":"Dynamics of hepatitis b virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy","volume":"177","author":"Zhang","year":"2013","journal-title":"Virus Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e916175","DOI":"10.12659\/MSM.916175","article-title":"The predictive value of the follicular output rate on pregnancy outcome of patients with polycystic ovary syndrome undergoing In vitro fertilization and embryo transfer","volume":"26","author":"Yang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.02.011","article-title":"A quantitative assessment of follicle size on oocyte developmental competence","volume":"90","author":"Rosen","year":"2008","journal-title":"Fertil Steril"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136312","article-title":"Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers","volume":"10","author":"Giorgetti","year":"1995","journal-title":"Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0337-6","article-title":"Association between the proportion of dominant follicles and oocyte developmental competence","volume":"31","author":"Li","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14708","article-title":"Ovarian response to follicle-stimulating hormone in women with polycystic ovary syndrome is diminished compared to ovulatory controls","volume":"97","author":"Harrison","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.09.042","article-title":"The use of aromatase inhibitors in in vitro fertilization","volume":"98","author":"Garcia-Velasco","year":"2012","journal-title":"Fertil Steril"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.11.034","article-title":"Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells","volume":"87","author":"Cai","year":"2007","journal-title":"Fertil Steril"},{"key":"B45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","article-title":"Letrozole supplementation during controlled ovarian stimulation in expected high responders: A pilot randomized controlled study","volume":"17","author":"Yang","year":"2019","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1072170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T06:24:15Z","timestamp":1677824655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1072170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":45,"alternative-id":["10.3389\/fendo.2023.1072170"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1072170","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1072170"}}